Unknown

Dataset Information

0

Investigation of 2 models to set and evaluate quality targets for hb a1c: biological variation and sigma-metrics.


ABSTRACT:

Background

A major objective of the IFCC Task Force on Implementation of HbA1c Standardization is to develop a model to define quality targets for glycated hemoglobin (Hb A1c).

Methods

Two generic models, biological variation and sigma-metrics, are investigated. We selected variables in the models for Hb A1c and used data of external quality assurance/proficiency testing programs to evaluate the suitability of the models to set and evaluate quality targets within and between laboratories.

Results

In the biological variation model, 48% of individual laboratories and none of the 26 instrument groups met the minimum performance criterion. In the sigma-metrics model, with a total allowable error (TAE) set at 5 mmol/mol (0.46% NGSP), 77% of the individual laboratories and 12 of 26 instrument groups met the 2σ criterion.

Conclusions

The biological variation and sigma-metrics models were demonstrated to be suitable for setting and evaluating quality targets within and between laboratories. The sigma-metrics model is more flexible, as both the TAE and the risk of failure can be adjusted to the situation-for example, requirements related to diagnosis/monitoring or international authorities. With the aim of reaching (inter)national consensus on advice regarding quality targets for Hb A1c, the Task Force suggests the sigma-metrics model as the model of choice, with default values of 5 mmol/mol (0.46%) for TAE and risk levels of 2σ and 4σ for routine laboratories and laboratories performing clinical trials, respectively. These goals should serve as a starting point for discussion with international stakeholders in the field of diabetes.

SUBMITTER: Weykamp C 

PROVIDER: S-EPMC4946649 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Investigation of 2 models to set and evaluate quality targets for hb a1c: biological variation and sigma-metrics.

Weykamp Cas C   John Garry G   Gillery Philippe P   English Emma E   Ji Linong L   Lenters-Westra Erna E   Little Randie R RR   Roglic Gojka G   Sacks David B DB   Takei Izumi I  

Clinical chemistry 20150303 5


<h4>Background</h4>A major objective of the IFCC Task Force on Implementation of HbA1c Standardization is to develop a model to define quality targets for glycated hemoglobin (Hb A1c).<h4>Methods</h4>Two generic models, biological variation and sigma-metrics, are investigated. We selected variables in the models for Hb A1c and used data of external quality assurance/proficiency testing programs to evaluate the suitability of the models to set and evaluate quality targets within and between labor  ...[more]

Similar Datasets

| S-EPMC6050189 | biostudies-literature
| S-EPMC7843286 | biostudies-literature
2013-12-13 | GSE53204 | GEO
| S-EPMC7305563 | biostudies-literature
| S-EPMC6039160 | biostudies-literature
| S-EPMC4454619 | biostudies-literature
| S-EPMC10229252 | biostudies-literature
| S-EPMC5427619 | biostudies-literature
| S-EPMC8728170 | biostudies-literature
| S-EPMC9287698 | biostudies-literature